BioAsia 2024 to put spotlight on role of data & AI in reshaping future of lifesciences

New Delhi: BioAsia, the pioneering annual event dedicated to the lifesciences sector, is all set to host its 21st edition, BioAsia 2024 from February 26 to 28, 2024 in Hyderabad.

The event themed “Data and AI: Redefining Possibilities,” is aimed at transforming the future of lifesciences.

The keynote speakers include Dave Ricks, CEO of Eli Lilly, Dr. Chris Boerner, Incoming CEO of BMS, Geoff Martha, Chairman and CEO, Medtronic, Christophe Weber, CEO of Takeda and Nobel Laureate Prof. Gregg Semenza.

These keynote speakers span the breadth of lifesciences expertise, making BioAsia 2024 an unparalleled forum and networking opportunity.

“BioAsia’s global prominence reflects Telangana’s unwavering commitment to innovation and research. We are privileged to host these visionary leaders who are shaping the future of healthcare,” said the Minister for Industries and Commerce, IT, Electronics & Communications KT Rama Rao.

As per Shakthi M.Nagappan, CEO of Telangana Lifesciences and BioAsia, “BioAsia 2024 is a game-changer, attracting the world’s brightest life sciences minds. The participation of global CEOs and visionaries underscores BioAsia’s growing global influence. We are hopeful that some more influential leaders will join this already impressive line-up.”

BioVoice News is one of the leading media partners for the event.